Literature DB >> 17002616

Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.

L Poirel1, E Lebessi, C Héritier, A Patsoura, M Foustoukou, P Nordmann.   

Abstract

Twelve non-repetitive Acinetobacter baumannii isolates producing the carbapenem-hydrolysing oxacillinase OXA-58 were recovered from patients in the same paediatric hospital in Athens, Greece, between November 2003 and May 2005. All isolates were clonally related, but the bla(OXA-58) gene was not always plasmid-located and there were variations in the DNA sequences surrounding the OXA-58 gene in different isolates. This study emphasises the importance of the bla(OXA-58) carbapenemase gene in conferring carbapenem resistance among A. baumannii isolates in Greece.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17002616     DOI： 10.1111/j.1469-0691.2006.01537.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  16 in total

1.  Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9.

Authors:  Samy Figueiredo; Laurent Poirel; Anna Papa; Vassiliki Koulourida; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Authors:  Sara Marti; Javier Sánchez-Céspedes; M Dolores Blasco; Marc Ruiz; Paula Espinal; Verónica Alba; Felipe Fernández-Cuenca; Alvaro Pascual; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

3.  Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.

Authors:  Olga Tsiatsiou; Εlias Iosifidis; Aspasia Katragkou; Vasiliki Dimou; Kosmas Sarafidis; Theodoros Karampatakis; Charalampos Antachopoulos; Anagnostina Orfanou; Athanasios Tsakris; Vasiliki Drossou-Agakidou; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2014-07-02       Impact factor: 3.183

4.  Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Authors:  C Routsi; M Pratikaki; E Platsouka; C Sotiropoulou; S Nanas; V Markaki; C Vrettou; O Paniara; H Giamarellou; C Roussos
Journal:  Infection       Date:  2010-03-12       Impact factor: 3.553

5.  Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii.

Authors:  Alessia Bertini; Laurent Poirel; Sandrine Bernabeu; Daniela Fortini; Laura Villa; Patrice Nordmann; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

6.  Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing.

Authors:  Laura Camarena; Vincent Bruno; Ghia Euskirchen; Sebastian Poggio; Michael Snyder
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

7.  Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.

Authors:  Laurent Poirel; Wejdene Mansour; Olfa Bouallegue; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.

Authors:  Raffaele Zarrilli; Domenico Vitale; Anna Di Popolo; Maria Bagattini; Ziad Daoud; Asad U Khan; Claude Afif; Maria Triassi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

Review 10.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.